ANIK is Anika Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $20.81. Market cap: $278M. Capital Quality Rank: 76/100 — Elite compounder.
Stock snapshot
| Price | $20.81 |
| Market cap | $278M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 76 / 100 · Elite compounder |
| ROIC (TTM) | -10.2% |
| Revenue CAGR (3y) | -0.3% |
| Shareholder buyback yield | 2.66% |
| Altman Z-score zone | Safe |
About ANIK
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Related non-dividend companies
Other non-dividend stocks investors research alongside ANIK. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ANIK's current stock price?
ANIK (Anika Therapeutics, Inc.) is currently trading at $20.81.
Does ANIK pay a dividend?
ANIK (Anika Therapeutics, Inc.) does not currently pay a regular dividend.
What is ANIK's Capital Quality Rank?
ANIK has a Capital Quality Rank of 76/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track ANIK in DiviDrip
Add ANIK to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ANIK and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.